Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Unique molecular assay, a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of myeloma, supports clinical decision-making and personalized treatment strategies.”
Title: Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
Authors: Andrea Poletti, Barbara Taurisano, Gaia Mazzocchetti, Marta Lionetti, Marina Martello, Viola Meixian Vuong, Vincenza Solli, Giulia Marzocchi, Akihiro Maeda, Ilaria Vigliotta, Enrica Borsi, Silvia Armuzzi, Ignazia Pistis, Alessio Marella, Sonia Fabris, Paola Tacchetti, Katia Mancuso, Ilaria Rizzello, Lucia Pantani, Nicoletta Testoni, Michele Cavo, Elena Zamagni, Niccolò Bolli, Carolina Terragna.
You can read the Full Article in Haematologica.
More posts featuring Robert Orlowski.
